Related references
Note: Only part of the references are listed.Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis A Randomized, Placebo-controlled Clinical Trial
Glenn L. Gordon et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
Jean Lachaine et al.
BMC GASTROENTEROLOGY (2013)
Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials
G. R. Lichtenstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Practical Usefulness of Minor Grooves of the Hepatic Surface for Liver Resection
Jae Hoon Lee et al.
HEPATO-GASTROENTEROLOGY (2012)
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
Gianmichele Meucci et al.
INFLAMMATORY BOWEL DISEASES (2012)
Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis
Sunanda Kane et al.
INFLAMMATORY BOWEL DISEASES (2012)
Mesalamine in the treatment and maintenance of remission of ulcerative colitis
Maggie Ham et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
W. Kruis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis
Sandro Ardizzone et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
JOURNAL OF CROHNS & COLITIS (2011)
Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial
G. R. Lichtenstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Asher Kornbluth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2010)
Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
Axel U. Dignass et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
5-ASA in ulcerative colitis: Improving treatment compliance
Cosimo Prantera et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Ulcerative colitis:: Patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort
Ole Hoie et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
5-aminosalicylates and renal function in inflammatory bowel disease:: A systematic review
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2007)
Systematic review: adherence issues in the treatment of ulcerative colitis
SV Kane
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: The ASCEND II trial
SB Hanauer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom
AF Muller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis
EV Loftus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease
MJ Shale et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Medication Nonadherence and the outcomes of patients with quiescent ulcerative colitis
S Kane et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Share Paper
